|
Development and evaluation of a truncated recombinant ADAMT13 micro-particle with extended release and enhanced protease plasmatic activity
Development and evaluation of a truncated recombinant ADAMT13 micro-particle with extended release and enhanced protease plasmatic activity
Background
Blood coagulation is an essential physiological process where the blood changes from a liquid form into a thicker, gel-like form in response to a blood vessel injury thereby preventing excessive blood...
Published: 6/26/2025
|
Updated: 6/21/2023
|
Inventor(s): Daniel Kohane, Juan Ibla, Upendra Katneni, Chava Kimchi-Sarfaty
Keywords(s): Cardiovascular, Molecules/ Proteins, Therapeutic
Category(s): Technology Classifications > Invention Type, Technology Classifications > Invention Type > Therapeutics, Technology Classifications > Disease Area, Technology Classifications > Disease Area > Hematology, Technology Classifications > Invention Type > Therapeutics > Protein
|
